FDA approves Afinitor (everolimus) for treatment of metastatic breast cancer

The US Food and Drug Administration (FDA) has approved the much awaited Afinitor® (everolimus) from Novartis that was part of the successful BOLERO2 study. Based on the positive results of the study, we have all been waiting for the approval of this new drug to the tool kit for advanced breast cancer.

F.D.A. Approves Drugs for (breast) Cancer and (multiple) Myeloma. By Andrew Pollack. In The New York Times 7-20-12

5 6 7 8
© 2004–2012 Donna Peach. All rights reserved.
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s